Provided by Tiger Trade Technology Pte. Ltd.

Personalis

16.00
-0.0600-0.37%
Post-market: 16.000.00000.00%19:54 EDT
Volume:1.84M
Turnover:29.52M
Market Cap:1.71B
PE:-14.58
High:16.24
Open:16.19
Low:15.98
Close:16.06
52wk High:18.89
52wk Low:4.96
Shares:107.00M
Float Shares:72.63M
Volume Ratio:0.67
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0976
EPS(LYR):-0.9107
ROE:-50.32%
ROA:-25.03%
PB:7.28
PE(LYR):-17.57

Loading ...

Personalis Has Already Doubled—Is Merck About To Trigger Another Surge?

Smartkarma
·
Jul 20

Personalis price target raised to $17 from $12 at Needham

TIPRANKS
·
Jul 17

Needham Raises Price Target on Personalis to $17 From $12, Keeps Buy Rating

MT Newswires Live
·
Jul 17

Personalis is Maintained at Buy by Needham

Dow Jones
·
Jul 17

Personalis attracting takeover interest, Street Insider says

TIPRANKS
·
Jul 17

Personalis moves off low after blog claims company exploring possible sale

TIPRANKS
·
Jul 17

Personalis President, CMO Richard Chen Sells 100,000 Shares for $1.52 Million

Reuters
·
Jul 16

Personalis Inc : TD Cowen Raises Target Price to $18 from $10

THOMSON REUTERS
·
Jul 15

Personalis Receives UK Regulatory Marking for Disease Detection Technology

MT Newswires Live
·
Jul 14

Personalis’ NeXT Personal test granted UKCA marking

TIPRANKS
·
Jul 14

Personalis Wins UKCA Mark for Next Personal Dx MRD Test in Great Britain

Reuters
·
Jul 14

Personalis CEO Christopher M. Hall Disposes of 100,000 Common Shares for $1.51 Million

Reuters
·
Jul 10

Personalis is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 10

Personalis price target raised to $13 from $9 at Morgan Stanley

TIPRANKS
·
Jul 09

Personalis Cfo/coo Aaron Tachibana Disposes of 4,982 Common Shares for $69,748

Reuters
·
Jun 30

Personalis CEO Christopher M. Hall Disposes of 100,000 Common Shares Worth $1.32 Million

Reuters
·
Jun 27

Personalis (PSNL) Stock Could Be 10% Undervalued After ASCO Cancer Data

Simply Wall St.
·
Jun 17

How Investors May Respond To Personalis (PSNL) CE Mark Win For Its MRD Blood Collection Kits

Simply Wall St.
·
Jun 15

A Look At Personalis (PSNL) Valuation After New ASCO Data On NeXT Personal MRD Platform

Simply Wall St.
·
Jun 09

Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing

MT Newswires Live
·
Jun 09